Potentiation of miniature endplate potential frequency by ATP in Xenopus tadpoles

• Published in: British journal of pharmacology 1993-01, Vol.108 (1), p.236-241
• Main Authors: Fu, Wen‐Mei, Yang, Shiau‐Hui, Lin‐Shiau, Shoei‐Yn
• Format: Article
• Language: English
• Subjects: Acetylcholine - metabolism; ACh release; Adenosine Diphosphate - pharmacology; Adenosine Monophosphate - pharmacology; Adenosine Triphosphate - analogs & derivatives; Adenosine Triphosphate - metabolism; Adenosine Triphosphate - pharmacology; Animals; ATP; Enzyme Activation; Guanosine Triphosphate - pharmacology; Membrane Potentials - drug effects; Microelectrodes; Motor Endplate - drug effects; Motor Endplate - physiology; protein kinase activation; Protein Kinases - metabolism; Tetradecanoylphorbol Acetate - pharmacology; Xenopus laevis
• ISSN: 0007-1188; 1476-5381
• DOI: 10.1111/j.1476-5381.1993.tb13468.x

1 Extracellular application of ATP (1 mm), a substance co‐stored and co‐released with acetylcholine in peripheral nervous systems, potentiated the spontaneous secretion of acetylcholine (ACh) but had no effect on the amplitude and decay time constant of miniature endplate potentials (m.e.p.ps) at neuromuscular synapses in Xenopus tadpoles. 2 α,β‐Methylene ATP (0.3 mm) and GTP (1 mm) were also effective in increasing m.e.p.p. frequency. On the other hand, ADP, AMP and adenosine (all at 1 mm) decreased m.e.p.p. frequency. 3 Unlike the transient effect of ATP analogue and GTP on m.e.p.p. frequency, the phorbol ester TPA (2 μm) which is a protein kinase C activator, increased m.e.p.p. frequency consistently and the effects lasted as long as the presence of TPA. 4 Staurosporine (0.5 μm) and H‐7 (10 μm), which are protein kinase C inhibitors, each decreased the basal level of m.e.p.p. frequency and markedly inhibited the effects of both ATP and TPA. 5 These results suggest that there is a basal activity of cytosolic protein kinases in the nerve terminals of Xenopus tadpoles and the effect of ATP is probably mediated by the binding of membrane surface purinoceptors which in turn activates cytosolic protein kinases and increases ACh release.